BSE filing, NSE: MIHIKA. Summary written from the filing by ALFA Finder's alert engine.
Mihika Industries Ltd: key numbers
- Share price
- ₹11.55
- Market cap
- ₹11.55 Cr
- Revenue (annual)
- ₹2.68 Cr
- Net profit (annual)
- ₹0.09 Cr
- P/E (TTM)
- 139.7×Sector 36.4×
- Promoter holding
- 47.14%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mihika Industries Ltd
All →Mihika Industries Board Meeting Date
Mihika Industries will hold a Rights Issue Committee meeting on November 2, 2026. It will decide the rights issue price, ratio and record date.
Mihika Industries Annual General Meeting
Mihika Industries Ltd held its 43rd Annual General Meeting on September 1, 2026. Shareholders considered and discussed various ordinary and special business resolutions.
Mihika Industries Other Announcement
Mihika Industries Limited reported the resignation of its Statutory Auditor, S K Bhavsar & Company, effective August 10, 2026, due to pre-existing professional commitments.
Mihika Industries Management Change
Mihika Industries reported the resignation of Statutory Auditor S K Bhavsar & Company. The company also appointed Kapil Kumar Aggarwal & Associates as the new Statutory Auditor.
Mihika Industries Annual General Meeting
Mihika Industries Limited has submitted its Annual Report for the financial year 2025-26. The company will hold its 43rd Annual General Meeting on 1st September 2026.
Mihika Industries Board Meeting Outcome
Mihika Industries appointed new statutory and secretarial auditors following board meeting approvals. The board also approved shifting the registered office from Kolkata to Ahmedabad.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.